Luis Martinez-Trapiella

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry.

Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry.

Journal: Rheumatology (Oxford, England)

Published: April 21, 2025

Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival.

Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival.

Journal: Clinical and experimental rheumatology

Published: May 08, 2023

Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry.

Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry.

Journal: Seminars in arthritis and rheumatism

Published: March 07, 2022

Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature.

Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: May 03, 2021

Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].

Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].

Journal: Autoimmunity reviews

Published: March 26, 2021

The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).

The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).

Journal: Rheumatology (Oxford, England)

Published: March 07, 2020

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

Journal: Autoimmunity reviews

Published: December 12, 2019

Scleroderma-like syndrome associated with pembrolizumab.

Scleroderma-like syndrome associated with pembrolizumab.

Journal: Journal of scleroderma and related disorders

Published: October 24, 2019

Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement.

Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement.

Journal: Clinical and experimental rheumatology

Published: May 31, 2019

Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study.

Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study.

Journal: The Journal of rheumatology

Published: January 25, 2019

Valvulopathy in scleroderma is not always autoimmunity.

Valvulopathy in scleroderma is not always autoimmunity.

Journal: Reumatologia clinica

Published: August 29, 2018

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.

Journal: Clinical rheumatology

Published: June 23, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026